MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0013941
Standard Pharmaceuticals Ltd - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹35.1 Cr
▲ 74% YoY
Net profit · FY 2026
₹22.69 Lakh
Net margin 0.6%
EBITDA · FY 2026
₹3.33 Cr
EBITDA margin 9.5%
Authorised capital
₹13.5 Cr
Registered with MCA
Paid-up capital
₹13.41 Cr
Issued & subscribed
Open charges
₹21.36 Cr
Satisfied ₹45.3 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
70
Provident fund records
About Standard Pharmaceuticals Ltd
Data last updated:
Standard Pharmaceuticals Ltd is a public limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 December 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1995PLC075698. Its GSTIN is 19AADCS9018E1ZA (West Bengal).
The company has an authorised share capital of ₹13.5 Cr and a paid-up capital of ₹13.41 Cr. It is led by directors including Omesh Kumar Sethi (Managing Director) and Tarun Mall Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 27 Mirza Galib Street, Kolkata, West Bengal, India – 700016.
As per the financials filed for FY 2026, the company reported a revenue of ₹35.1 Cr, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹22.69 Lakh (net margin 0.6%) and EBITDA of ₹3.33 Cr (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 43% over five years.
The company has about 70 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹21.36 Cr and satisfied charges of ₹45.3 Cr on record. Court records list 63 cases involving the company, including 33 filed by the company and 30 filed against it; 12 cases are pending.
Standard Pharmaceuticals Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0013941). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website standardpharmaceuticals.com.
Company details
CIN U24232WB1995PLC075698
Registration Number 075698
Incorporation Date 04 December 1995
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0013941
CIN history
Standard Pharmaceuticals has one previous CIN (Corporate Identification Number): U75698WB1995PLC075698. The current CIN is U24232WB1995PLC075698, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232WB1995PLC075698 | Current |
| U75698WB1995PLC075698 | Previous |
Key People
Omesh Kumar Sethi Managing Director Tarun Mall Kumar Whole-Time Director Bhabani Prasad Dey Director Recognitions & Rankings of Standard Pharmaceuticals
Contact details
Standard Pharmaceuticals Ltd's registered office is in Kolkata, West Bengal. Its website is standardpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address27 Mirza Galib Street, Kolkata, West Bengal, India – 700016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Standard Pharmaceuticals Ltd, buy the company report.
Comprehensive company report
Standard Pharmaceuticals Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Standard Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Standard Pharmaceuticals Ltd, buy the company report.
Financials of Standard Pharmaceuticals Ltd
FY 2026 filings availableStandard Pharmaceuticals Ltd reported revenue of ₹35.1 Cr (up 74% YoY) for FY 2026.
Revenue · FY 2026
₹35.1 Cr ▲ 74%
Net profit · FY 2026
₹22.69 Lakh margin 0.6%
EBITDA · FY 2026
₹3.33 Cr margin 9.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 32%
5 years · compounded
▲ 43%
EBITDA CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 20%
5 years · compounded
▲ 42%
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 74% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹35.1 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Standard Pharmaceuticals Ltd, buy the company report.
Board of directors of Standard Pharmaceuticals Ltd
Standard Pharmaceuticals has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarun Mall Kumar | Whole-Time Director | 18 Feb 2009 | 17 Years 8 Months | Current |
| Bhabani Prasad Dey | Director | 25 May 2016 | 10 Years 5 Months | Current |
| Omesh Kumar Sethi Also directs: Sol Medic Limited, Stanvie Industries Private Limited | Managing Director | 30 Sep 2015 | 11 Years 1 Months | Current |
| Dwijasis Bhattacharya | Additional Director | 31 Oct 2025 | 1 Years 0 Months | Current |
Auditor
Standard Pharmaceuticals Ltd is audited by Kedia Dhandharia & Co. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kedia Dhandharia & Co. | FY 2026 | 326659E |
Shareholding
The shareholding of Standard Pharmaceuticals Ltd is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Standard Pharmaceuticals Ltd, buy the company report.
Charges & borrowings
Open charges
₹21.36 Cr
Satisfied charges
₹45.3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Apr 2018 | 100193235 | Others | ₹1.1 Cr | Open | |
| 25 Aug 2017 | 100120462 | Others | ₹12.85 Cr | Open | |
| 01 Nov 1999 | 90247989 | The Federal Bank Limited | ₹7.41 Cr | Open | |
| 27 Jun 2018 | 100188295 | Tata Capital Financial Services Limited | ₹84.5 Lakh | Satisfied | |
| 26 Feb 2016 | 10622564 | Religare Finvest Limited | ₹2 Cr | Satisfied |
To see the full charge records of Standard Pharmaceuticals Ltd, buy the company report.
Total charge records: 13 View all charges
Legal cases
Standard Pharmaceuticals Ltd has 63 court cases on record: 33 filed by Standard Pharmaceuticals, 30 filed against it. 12 cases are pending and 51 are disposed.
Total cases
63
Filed by the company
33
Filed against the company
30
Pending
12
Disposed
51
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 33 | 5 | 3 |
| District courts | 26 | 24 | 9 |
| Supreme Court | 2 | 0 | 0 |
| NCLT | 2 | 1 | 0 |
Cases on record (5 of 63)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Agarwal Life Sciences Pvt Ltd | Pending |
| District court, Calcutta, West Bengal | Court case (TS) | Filed against the company by Pushppalki Reality Pvt. Ltd. | Disposed |
| District court, South East, Delhi | Cheque dishonour complaint | Filed against the company by Udi Sales Pvt Ltd | Disposed |
| NCLT, Kolkata | Insolvency matter | Filed against the company by Aquatic Remedies Ltd. | Disposed |
| High Court | Civil suit | Filed by the company against Standard Health Private Limited. | Disposed |
To see the full case history of Standard Pharmaceuticals Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Standard Pharmaceuticals Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Standard Pharmaceuticals Ltd has a workforce of 70 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
70
Active EPFO establishments
1
Employee growth
2.9%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 70 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Standard Pharmaceuticals Ltd, buy the company report.
GST
Standard Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCS9018E1ZA | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Standard Pharmaceuticals Ltd, buy the company report.
Recent activity
Standard Pharmaceuticals Ltd has 16 board changes on record since 2008: 4 appointments and 12 cessations. The latest: Dwijasis Bhattacharya was appointed as Additional Director on 31 Oct 2025.
Filing
Standard Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Kolkata.
Appointed
Dwijasis Bhattacharya was appointed as Additional Director.
AGM
Standard Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 27 Jun 2018 via Charge ID 100188295 with Tata Capital Financial Services Limited was fully satisfied on 28 Aug 2024.
Charges
A charge with Tata Capital Financial Services Limited amounted to Rs. 0.85 Cr with Charge ID 100188295 was registered on 27 Jun 2018.
Charges
A charge with Others amounted to Rs. 1.10 Cr with Charge ID 100193235 was registered on 27 Apr 2018.
Charges
A charge with Others amounted to Rs. 12.85 Cr with Charge ID 100120462 was registered on 25 Aug 2017.
Charges
A charge registered on 26 Feb 2016 via Charge ID 10622564 with Religare Finvest Limited was fully satisfied on 18 Aug 2017.
Charges
A charge registered on 21 Nov 2015 via Charge ID 10603515 with Religare Finvest Limited was fully satisfied on 18 Aug 2017.
Charges
A charge registered on 21 Jul 2001 via Charge ID 90244613 with The Federal Bank Ltd. was fully satisfied on 10 Aug 2017.
Charges
A charge registered on 07 Apr 2006 via Charge ID 80056339 with The Federal Bank Ltd was fully satisfied on 08 Dec 2016.
Ceased
Bhabani Prasad Dey ceased to be Additional Director.
33 earlier events are in the company report.
Frequently asked questions
Standard Pharmaceuticals is an active public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 December 1995 (31+ years old) and is registered under CIN U24232WB1995PLC075698.
Standard Pharmaceuticals has 4 current directors:
- Omesh Kumar Sethi - Managing Director
- Tarun Mall Kumar - Whole-Time Director
- Bhabani Prasad Dey - Director
- Dwijasis Bhattacharya - Additional Director
The latest financial statements of Standard Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Standard Pharmaceuticals is 19AADCS9018E1ZA, registered in West Bengal.
The CIN (Corporate Identification Number) of Standard Pharmaceuticals is U24232WB1995PLC075698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Standard Pharmaceuticals has 63 court cases on record: 33 filed by the company and 30 filed against it. 12 are pending. Most are in the high courts.
Standard Pharmaceuticals was incorporated on 04 December 1995, making it 31+ years old. It is registered with the Registrar of Companies, Kolkata.
Dwijasis Bhattacharya was appointed as Additional Director on 31 Oct 2025. Bhabani Prasad Dey ceased to be Additional Director on 30 Sep 2016. Bhabani Prasad Dey was appointed as Director on 25 May 2016. Standard Pharmaceuticals has 16 board changes on record in total.
Yes, Standard Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0013941).
Standard Pharmaceuticals can be reached through the website standardpharmaceuticals.com. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages